C 2010

ATRIAL NATRIURETIC PEPTIDE: IS ANP ASSOCIATED WITH RESTENOSIS AFTER CORONARY ARTERY STENTING?

BIENERTOVÁ VAŠKŮ, Julie, Sushruth Ganesha SWAMY, Petr BIENERT and Ota HLINOMAZ

Basic information

Original name

ATRIAL NATRIURETIC PEPTIDE: IS ANP ASSOCIATED WITH RESTENOSIS AFTER CORONARY ARTERY STENTING?

Name in Czech

Souvisí atriální natriuretický faktor (ANP) s rozvojem restenózy po PCI?

Authors

BIENERTOVÁ VAŠKŮ, Julie (203 Czech Republic, guarantor), Sushruth Ganesha SWAMY (826 United Kingdom of Great Britain and Northern Ireland), Petr BIENERT (203 Czech Republic) and Ota HLINOMAZ (203 Czech Republic)

Edition

I. New York, Horizons in World Cardiovascular Research, p. xxx, 8 pp. Horizons in World Cardiovascular Research, Volume2, 2010

Publisher

Nova Science Publishers, Inc.

Other information

Language

English

Type of outcome

Kapitola resp. kapitoly v odborné knize

Field of Study

Genetics and molecular biology

Country of publisher

United States of America

Confidentiality degree

obsah podléhá obchodnímu tajemství

RIV identification code

RIV/00216224:14110/10:00043948

Organization unit

Faculty of Medicine

ISBN

978-1-61668-610-9

Keywords (in Czech)

atriální natriuretický faktor; polymorfismus; SNP; restenóza; PTCA

Keywords in English

Atrial natriuretic factor; polymorphism; SNP; restenosis; PTCA

Tags

International impact, Reviewed
Změněno: 19/5/2010 16:29, prof. MUDr. Julie Dobrovolná, Ph.D.

Abstract

V originále

*Atrial natriuretic factor (ANP) has shown over recent decades to play an emerging role in the regulation of coronary blood flow as well as systemic blood pressure. The common polymorphism in the atrial natriuretic peptide precursor gene (NPPA), +2238 T/C, was in the previous studies associated with hypertension as well as other cardiovascular conditions. The purpose of the study was to identify the possible relationship between the +2238 T/C polymorphism and restenosis in coronary arteries stented due to the coronary artery disease (CAD).

In Czech

*Atriální natriuretický faktor (ANP) je důležitým regulátorem průtoku krve koronárním řečištěm. Polymorfismusm +2238 T/C v genu pro prekurzor atriálního natriuretického faktoru byl již dříve asociován s koronární nemocí. V této studii jsme zkoumali efekt polymorfismu +2238 T/C na riziko vzniku restenózy po PCI s implantací stentu.